Acquired ATTR amyloidosis, also known as wild-type ATTR amyloidosis, occurs when a normally functioning protein in your blood begins to misfold and form harmful deposits in your organs without any genetic mutation being passed down through families. This condition develops with age and most commonly affects the heart, though it can also impact the nervous system and other tissues, leading to serious health challenges that require careful medical management.

Understanding Acquired ATTR Amyloidosis

Acquired ATTR amyloidosis represents one of two main forms of transthyretin amyloidosis, the other being hereditary ATTR amyloidosis. While hereditary forms result from genetic mutations passed down through families, acquired ATTR amyloidosis develops without any inherited genetic fault.^[1] This distinction is crucial because it means the condition can appear in people with no family history of the disease.

The condition centers around a protein called transthyretin, often shortened to TTR. Your liver produces this protein, and its normal job is to transport thyroid hormones and vitamin A throughout your bloodstream.^[2] In acquired ATTR amyloidosis, these transthyretin proteins become unstable for reasons not yet fully understood by medical researchers. The proteins break apart, fold incorrectly, and clump together to form abnormal deposits called amyloid fibrils.^[5]

These fibril clumps travel through your bloodstream and settle in various organs and tissues. When they accumulate in your heart, they cause the organ to thicken and stiffen, making it increasingly difficult for your heart to pump blood effectively throughout your body. This leads to a condition called cardiomyopathy, which is a disease of the heart muscle.^[2] Over time, if left untreated, this stiffening and weakening can progress to heart failure.

Epidemiology: Who Gets Acquired ATTR Amyloidosis

Medical experts acknowledge that acquired ATTR amyloidosis is probably more common than currently recognized. The disease appears to be significantly underdiagnosed, meaning many people who have it may not yet know.^[2] This underdiagnosis happens partly because the symptoms can resemble other more common heart conditions, and partly because awareness of the disease among healthcare providers has only recently increased.

Unlike the hereditary form of ATTR amyloidosis, which shows strong associations with certain ethnic groups and genetic backgrounds, acquired ATTR amyloidosis follows different demographic patterns. This form of the disease occurs for no known inherited reason and is also referred to as wild-type ATTR amyloidosis.^[1]

Age and sex appear to be the primary risk factors for acquired ATTR amyloidosis. The condition most commonly develops in males over the age of 65.^[2] This strong association with advancing age suggests that the aging process itself may play a role in causing the transthyretin proteins to become unstable and misfold. The predominance in males indicates that biological sex may also influence disease development, though researchers are still working to understand exactly why this occurs.

While cardiac amyloidosis was once considered a rare disease, recent improvements in imaging techniques have revealed that some patients previously diagnosed with other conditions, such as hypertensive heart disease or hypertrophic cardiomyopathy, may actually have been suffering from undiagnosed cardiac amyloidosis.^[8] This suggests that the true prevalence may be considerably higher than historical estimates indicated.

Causes: Why Does Acquired ATTR Amyloidosis Develop

The fundamental cause of acquired ATTR amyloidosis remains somewhat mysterious to medical science. Unlike hereditary ATTR amyloidosis, where a specific genetic mutation can be identified, acquired ATTR amyloidosis occurs without any detectable fault in the TTR gene.^[2] This means researchers cannot point to a single clear trigger that initiates the disease process.

What scientists do understand is the biological mechanism once the disease begins. Your liver continuously produces transthyretin proteins as part of normal body function. In acquired ATTR amyloidosis, these otherwise normal proteins become unstable and begin to misfold. When proteins misfold, they change shape in a way that prevents them from functioning properly and causes them to stick together.^[5]

These misfolded proteins aggregate into clumps called amyloid fibrils. Your bloodstream then carries these fibril clusters throughout your body, where they deposit in organs like your heart and nervous system. Over months and years, these deposits accumulate, interfering with normal organ structure and function. The physical presence of amyloid deposits damages tissue organization, and the proteins themselves may have direct toxic effects on cells.^[3]

The strong association with advanced age suggests that the aging process may somehow make transthyretin proteins more prone to misfolding. However, the exact biological changes that occur with aging to trigger this protein instability remain an active area of research. Some theories suggest that accumulated cellular damage over time, changes in how the liver produces proteins, or alterations in how the body clears abnormal proteins might all contribute to disease development.

Risk Factors: Who Is Most at Risk

Age stands out as the most significant risk factor for acquired ATTR amyloidosis. The condition predominantly affects individuals over 65 years of age, with risk increasing as people grow older.^[2] This age association is so strong that acquired ATTR amyloidosis is sometimes referred to as senile amyloidosis, reflecting its connection to the aging process.

Being male represents another major risk factor. Acquired ATTR amyloidosis occurs much more frequently in men than in women, though the biological reasons for this sex difference are not completely understood.^[5] Some researchers speculate that hormonal differences, variations in how male and female bodies produce or clear proteins, or other sex-linked biological factors might explain this disparity.

Because the condition appears to be widely underdiagnosed, certain groups may be at higher practical risk simply due to diagnostic patterns. Older men with symptoms that could indicate heart problems should be aware that acquired ATTR amyloidosis exists as a possibility, especially if their symptoms don’t fully match typical heart disease presentations or don’t respond well to standard heart failure treatments.

There is no evidence that lifestyle factors, dietary choices, environmental exposures, or behavioral habits influence the risk of developing acquired ATTR amyloidosis. This differs from many other diseases where modifiable risk factors play a significant role. The condition appears to develop primarily as a consequence of aging biology rather than external influences.

Symptoms: How Acquired ATTR Amyloidosis Affects the Body

The symptoms of acquired ATTR amyloidosis vary depending on which organs have been affected by amyloid deposits and how extensively the deposits have accumulated. You may not experience any symptoms early in the disease course, which is one reason diagnosis can be delayed.^[4] As the condition progresses, symptoms gradually become more noticeable and can significantly impact daily life.

When acquired ATTR amyloidosis affects the heart, which is the most common pattern, symptoms typically resemble those of heart failure. Shortness of breath is one of the most frequent complaints, particularly during physical activity or exertion.^[1] As the disease advances, you might experience difficulty breathing even while resting. This happens because the amyloid deposits make your heart muscle stiff and thick, reducing its ability to fill with blood properly and pump effectively.

Fatigue represents another common symptom that can be quite debilitating. You might feel unusually tired or weak, finding that activities you previously managed easily now leave you exhausted. This fatigue occurs because your heart struggles to pump enough oxygen-rich blood to meet your body’s needs.^[7]

Swelling, medically called edema, frequently develops in the ankles and legs. This happens when your weakened heart cannot pump blood efficiently, causing fluid to back up in your blood vessels and leak into surrounding tissues. Some people also develop fluid accumulation in the abdomen, creating a swollen, distended feeling.^[1]

Heart rhythm problems may occur as amyloid deposits disrupt the heart’s electrical system. You might experience palpitations, where you become aware of your heartbeat feeling irregular, too fast, or too strong. Some people develop atrial fibrillation, an irregular heart rhythm that can be the first symptom bringing them to medical attention.^[10] Fainting episodes or feelings of lightheadedness when standing up, called orthostatic hypotension, can also occur.

Chest pain or discomfort, similar to angina, sometimes develops. Additional symptoms might include dizziness, low blood pressure, and in some cases, digestive problems such as decreased appetite, nausea, or changes in bowel habits.^[4] Though acquired ATTR amyloidosis primarily affects the heart, it can also impact the nervous system, potentially causing numbness, tingling, or pain in the hands and feet.

Prevention: Can Acquired ATTR Amyloidosis Be Prevented

Because acquired ATTR amyloidosis occurs for reasons that are not yet fully understood, and because it appears to be primarily related to the aging process rather than lifestyle or environmental factors, there are currently no known prevention strategies. Unlike many diseases where specific behaviors or exposures can be modified to reduce risk, acquired ATTR amyloidosis does not appear to be influenced by diet, exercise, smoking, alcohol consumption, or other typical health-related choices.

This lack of preventive measures underscores the importance of early detection rather than prevention. Since age and male sex are the primary risk factors, and neither can be modified, the focus shifts to recognizing symptoms early and pursuing prompt diagnosis when symptoms develop.

Maintaining regular healthcare visits as you age becomes important for overall health monitoring. While routine screening for acquired ATTR amyloidosis is not currently standard practice, staying connected with healthcare providers means that if symptoms develop, they can be evaluated more quickly. Being aware that the condition exists, especially if you are an older man, helps ensure that you can describe symptoms accurately and advocate for thorough evaluation if standard treatments for other conditions don’t seem to work well.

Pathophysiology: How the Disease Changes Your Body

The pathophysiology of acquired ATTR amyloidosis involves a cascade of biological changes that progress over time. Understanding these changes helps explain why symptoms develop and how the disease affects your body’s function.

Under normal circumstances, your liver produces transthyretin proteins that circulate in your blood performing their transport functions. These proteins naturally exist as structures called tetramers, which means four protein molecules join together. This tetrameric structure is normally stable.^[8] In acquired ATTR amyloidosis, these tetramers become unstable and dissociate, meaning they break apart into individual protein molecules.

Once separated, the individual transthyretin proteins can misfold. Protein folding refers to the three-dimensional shape a protein takes, which determines its function. Misfolded proteins take on incorrect shapes that prevent them from working properly. Worse, misfolded transthyretin proteins have sticky properties that cause them to aggregate, or clump together, forming larger structures called amyloid fibrils.^[5]

These amyloid fibrils are insoluble, meaning they don’t dissolve back into the bloodstream. Instead, they deposit in the extracellular spaces between cells in various organs and tissues throughout your body. Your blood carries these fibril deposits to different locations, but in acquired ATTR amyloidosis, they most commonly accumulate in the heart and sometimes the nervous system.^[2]

In the heart, amyloid fibrils deposit primarily in the left ventricle, your heart’s main pumping chamber. As these deposits accumulate, they cause the heart muscle to thicken. This thickening is not the healthy kind that might occur with exercise, but rather an infiltration of abnormal protein material between heart muscle cells. The deposits also make the heart muscle increasingly stiff and rigid.^[5]

This stiffness creates a condition called restrictive cardiomyopathy. Your heart muscle becomes unable to relax and fill properly with blood during the resting phase between beats. When the heart cannot fill adequately, it cannot pump sufficient blood forward with each contraction. This reduced pumping capacity means less oxygen-rich blood reaches your body’s tissues and organs, explaining symptoms like fatigue and shortness of breath.

The amyloid deposits also have direct toxic effects on heart cells. Beyond the mechanical problems caused by stiffness, the abnormal proteins appear to damage cells and interfere with normal cellular functions. The combination of tissue disruption and direct toxicity progressively impairs heart function.^[3] Over time, this leads to heart failure if the disease is not treated.

When amyloid deposits affect the nervous system, they can damage nerve fibers, leading to peripheral neuropathy, which causes numbness, tingling, weakness, or pain in the limbs. The deposits can also affect the autonomic nervous system, which controls automatic body functions like blood pressure regulation, digestion, and bladder control, leading to symptoms in these areas.^[7]